ADAM29 anticorps (ADAM Metallopeptidase Domain 29) (AA 339-398)

Details for Product anti-ADAM29 Antibody No. ABIN524502, Fournisseur: Connectez-vous pour afficher
Antigène
  • CT73
  • svph1
  • a disintegrin and metallopeptidase domain 29
  • ADAM metallopeptidase domain 29
  • Adam29
  • ADAM29
Épitope
AA 339-398, partial
3
2
2
2
1
1
Reactivité
Humain
15
3
3
2
1
1
1
1
1
1
Hôte
Souris
10
5
Clonalité (Clone)
Monoclonal ()
Application
ELISA, Western Blotting (WB)
12
12
2
1
1
Options
Fournisseur
Connectez-vous pour afficher
Supplier Product No.
Connectez-vous pour afficher
Immunogène ADAM29 (NP_055084, 339 a.a. ~ 398 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Immunogen sequence: GMNHDEDTCR CSQPRCIMHE GNPPITKFSN CSYGDFWEYT VERTKCLLET VHTKDIFNVK
Clone 3A6
Isotype IgG1 kappa
 Réactivité croisée Humain
Autre désignation ADAM29 (ADAM29 Antibody Extrait)
Sujet Full Gene Name: ADAM metallopeptidase domain 29
Synonyms: svph1
ID gène 11086
NCBI Accession NP_055084, NM_014269
Domaine de recherche Proteolysis / Ubiquitin, Metalloprotease, Extracellular Matrix
Indications d'application Optimal working dilution should be determined by the investigator.
Commentaires

Product Quality tested by: Antibody Reactive Against Recombinant Protein.

Restrictions For Research Use only
Buffer In 1x PBS, pH 7.4
Conseil sur la manipulation Aliquot to avoid repeated freezing and thawing.
Stock -20 °C
Stockage commentaire Store at -20 °C or lower. Aliquot to avoid repeated freezing and thawing.
Supplier Images
ELISA image for anti-ADAM Metallopeptidase Domain 29 (ADAM29) (AA 339-398), (partial) antibody (ABIN524502) Detection limit for recombinant GST tagged ADAM29 is 0.3 ng/ml as a capture antibody.
 image for anti-ADAM Metallopeptidase Domain 29 (ADAM29) (AA 339-398), (partial) antibody (ABIN524502) Western Blot detection against Immunogen (32.34 KDa) .
Produit citée dans: Zhao, Jia, Jiang, Wang, DU, Cheng, Song: "ADAM29 Expression in Human Breast Cancer and its Effects on Breast Cancer Cells In Vitro." dans: Anticancer research, Vol. 36, Issue 3, pp. 1251-8, 2016 (PubMed).

Avez-vous cherché autre chose?